Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 347

1.

Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.

Ahn SS, Shin NY, Chang JH, Kim SH, Kim EH, Kim DW, Lee SK.

J Neurosurg. 2014 Aug;121(2):367-73. doi: 10.3171/2014.5.JNS132279. Epub 2014 Jun 20.

PMID:
24949678
2.

Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.

Sunwoo L, Choi SH, Park CK, Kim JW, Yi KS, Lee WJ, Yoon TJ, Song SW, Kim JE, Kim JY, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH, Chang KH.

J Magn Reson Imaging. 2013 Feb;37(2):351-8. doi: 10.1002/jmri.23838. Epub 2012 Sep 28.

PMID:
23023975
3.

Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation.

Yoon RG, Kim HS, Paik W, Shim WH, Kim SJ, Kim JH.

Eur Radiol. 2017 Jan;27(1):255-266. Epub 2016 Apr 5.

PMID:
27048531
4.

Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status.

Romano A, Calabria LF, Tavanti F, Minniti G, Rossi-Espagnet MC, Coppola V, Pugliese S, Guida D, Francione G, Colonnese C, Fantozzi LM, Bozzao A.

Eur Radiol. 2013 Feb;23(2):513-20. doi: 10.1007/s00330-012-2601-4. Epub 2012 Aug 10.

PMID:
22875158
5.

An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.

Drabycz S, Roldán G, de Robles P, Adler D, McIntyre JB, Magliocco AM, Cairncross JG, Mitchell JR.

Neuroimage. 2010 Jan 15;49(2):1398-405. doi: 10.1016/j.neuroimage.2009.09.049. Epub 2009 Sep 28.

PMID:
19796694
6.

Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.

Li C, Chen M, Li S, Zhao X, Zhang C, Luo X, Zhou C.

Acta Radiol. 2014 Mar;55(2):239-47. doi: 10.1177/0284185113494978. Epub 2013 Jul 26.

PMID:
23892233
7.

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.

Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, Otten P, Van Melle G, de Tribolet N, Stupp R.

Clin Cancer Res. 2004 Mar 15;10(6):1871-4.

8.

Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.

Choi HS, Kim AH, Ahn SS, Shin NY, Kim J, Lee SK.

Korean J Radiol. 2013 May-Jun;14(3):487-92. doi: 10.3348/kjr.2013.14.3.487. Epub 2013 May 2.

9.

Cerebral blood volume calculated by dynamic susceptibility contrast-enhanced perfusion MR imaging: preliminary correlation study with glioblastoma genetic profiles.

Ryoo I, Choi SH, Kim JH, Sohn CH, Kim SC, Shin HS, Yeom JA, Jung SC, Lee AL, Yun TJ, Park CK, Park SH.

PLoS One. 2013 Aug 19;8(8):e71704. doi: 10.1371/journal.pone.0071704. eCollection 2013.

10.

Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging.

Moon WJ, Choi JW, Roh HG, Lim SD, Koh YC.

Neuroradiology. 2012 Jun;54(6):555-63. doi: 10.1007/s00234-011-0947-y. Epub 2011 Aug 11.

PMID:
21833736
11.

Incremental Prognostic Value of ADC Histogram Analysis over MGMT Promoter Methylation Status in Patients with Glioblastoma.

Choi YS, Ahn SS, Kim DW, Chang JH, Kang SG, Kim EH, Kim SH, Rim TH, Lee SK.

Radiology. 2016 Oct;281(1):175-84. doi: 10.1148/radiol.2016151913. Epub 2016 Apr 27.

PMID:
27120357
12.

Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas.

Ramakrishnan V, Kushwaha D, Koay DC, Reddy H, Mao Y, Zhou L, Ng K, Zinn P, Carter B, Chen CC.

Cancer Biomark. 2011-2012;10(3-4):185-93. doi: 10.3233/CBM-2012-0245.

PMID:
22674304
13.

Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study.

Costa BM, Caeiro C, Guimarães I, Martinho O, Jaraquemada T, Augusto I, Castro L, Osório L, Linhares P, Honavar M, Resende M, Braga F, Silva A, Pardal F, Amorim J, Nabiço R, Almeida R, Alegria C, Pires M, Pinheiro C, Carvalho E, Lopes JM, Costa P, Damasceno M, Reis RM.

Oncol Rep. 2010 Jun;23(6):1655-62.

PMID:
20428822
14.

Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres.

Sciuscio D, Diserens AC, van Dommelen K, Martinet D, Jones G, Janzer RC, Pollo C, Hamou MF, Kaina B, Stupp R, Levivier M, Hegi ME.

Clin Cancer Res. 2011 Jan 15;17(2):255-66. doi: 10.1158/1078-0432.CCR-10-1931. Epub 2010 Nov 19.

15.

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference.

Morandi L, Franceschi E, de Biase D, Marucci G, Tosoni A, Ermani M, Pession A, Tallini G, Brandes A.

BMC Cancer. 2010 Feb 18;10:48. doi: 10.1186/1471-2407-10-48.

16.

Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading.

Inano R, Oishi N, Kunieda T, Arakawa Y, Yamao Y, Shibata S, Kikuchi T, Fukuyama H, Miyamoto S.

Neuroimage Clin. 2014 Aug 7;5:396-407. doi: 10.1016/j.nicl.2014.08.001. eCollection 2014.

17.
18.

The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival.

Choi YS, Kim DW, Lee SK, Chang JH, Kang SG, Kim EH, Kim SH, Rim TH, Ahn SS.

AJNR Am J Neuroradiol. 2015 Dec;36(12):2235-41. doi: 10.3174/ajnr.A4449. Epub 2015 Sep 3.

19.

Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.

Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L, Filippini G, Broggi G, Boiardi A, Finocchiaro G.

Clin Cancer Res. 2007 May 1;13(9):2606-13.

20.

A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.

Abhinav K, Aquilina K, Gbejuade H, La M, Hopkins K, Iyer V.

Clin Neurol Neurosurg. 2013 Aug;115(8):1375-8. doi: 10.1016/j.clineuro.2012.12.023. Epub 2013 Jan 18.

PMID:
23333005

Supplemental Content

Support Center